BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 32937046)

  • 1. Randomized Trial of Nocturnal Oxygen in Chronic Obstructive Pulmonary Disease.
    Lacasse Y; Sériès F; Corbeil F; Baltzan M; Paradis B; Simão P; Abad Fernández A; Esteban C; Guimarães M; Bourbeau J; Aaron SD; Bernard S; Maltais F;
    N Engl J Med; 2020 Sep; 383(12):1129-1138. PubMed ID: 32937046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-center, randomized, placebo-controlled trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease: a study protocol for the INOX trial.
    Lacasse Y; Bernard S; Sériès F; Nguyen VH; Bourbeau J; Aaron S; Maltais F;
    BMC Pulm Med; 2017 Jan; 17(1):8. PubMed ID: 28069009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation.
    ; Albert RK; Au DH; Blackford AL; Casaburi R; Cooper JA; Criner GJ; Diaz P; Fuhlbrigge AL; Gay SE; Kanner RE; MacIntyre N; Martinez FJ; Panos RJ; Piantadosi S; Sciurba F; Shade D; Stibolt T; Stoller JK; Wise R; Yusen RD; Tonascia J; Sternberg AL; Bailey W
    N Engl J Med; 2016 Oct; 375(17):1617-1627. PubMed ID: 27783918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Nocturnal Oxygen Therapy on Nocturnal Hypoxemia and Sleep Apnea Among Patients With Chronic Obstructive Pulmonary Disease Traveling to 2048 Meters: A Randomized Clinical Trial.
    Tan L; Latshang TD; Aeschbacher SS; Huber F; Flueck D; Lichtblau M; Ulrich S; Hasler ED; Scheiwiller PM; Ulrich S; Bloch KE; Furian M
    JAMA Netw Open; 2020 Jun; 3(6):e207940. PubMed ID: 32568400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating nocturnal oxygen desaturation in COPD--revised.
    Lacasse Y; Sériès F; Vujovic-Zotovic N; Goldstein R; Bourbeau J; Lecours R; Aaron SD; Maltais F
    Respir Med; 2011 Sep; 105(9):1331-7. PubMed ID: 21561753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nocturnal oxygen therapy in patients with chronic obstructive pulmonary disease: a survey of Canadian respirologists.
    Lacasse Y; Sériès F; Martin S; Maltais F
    Can Respir J; 2007 Sep; 14(6):343-8. PubMed ID: 17885694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Domiciliary oxygen for chronic obstructive pulmonary disease.
    Cranston JM; Crockett AJ; Moss JR; Alpers JH
    Cochrane Database Syst Rev; 2005 Oct; 2005(4):CD001744. PubMed ID: 16235285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of isolated nocturnal oxygen desaturations on serum hs-CRP and IL-6 in patients with chronic obstructive pulmonary disease.
    Macrea MM; Owens RL; Martin T; Smith D; Oursler KK; Malhotra A
    Clin Respir J; 2019 Feb; 13(2):120-124. PubMed ID: 30638307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of Alpha-1 Antitrypsin-Deficient Individuals in the Long-term Oxygen Treatment Trial and Comparison with Other Subjects with Chronic Obstructive Pulmonary Disease.
    Stoller JK; Aboussouan LS; Kanner RE; Wilson LA; Diaz P; Wise R;
    Ann Am Thorac Soc; 2015 Dec; 12(12):1796-804. PubMed ID: 26653189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nocturnal desaturation: predictors and the effect on sleep patterns in patients with chronic obstructive pulmonary disease and concomitant mild daytime hypoxemia.
    Zanchet RC; Viegas CA
    J Bras Pneumol; 2006; 32(3):207-12. PubMed ID: 17273609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Dexamethasone on Nocturnal Oxygenation in Lowlanders With Chronic Obstructive Pulmonary Disease Traveling to 3100 Meters: A Randomized Clinical Trial.
    Furian M; Lichtblau M; Aeschbacher SS; Estebesova B; Emilov B; Sheraliev U; Marazhapov NH; Mademilov M; Osmonov B; Bisang M; Ulrich S; Latshang TD; Ulrich S; Sooronbaev TM; Bloch KE
    JAMA Netw Open; 2019 Feb; 2(2):e190067. PubMed ID: 30794302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supplemental oxygen in patients with stable chronic obstructive pulmonary disease: evidence from Nocturnal Oxygen Treatment Trial to Long-term Oxygen Treatment Trial.
    Hatipoğlu U; Stoller JK
    Curr Opin Pulm Med; 2018 Mar; 24(2):179-186. PubMed ID: 29319542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Home oxygen for moderate hypoxaemia in chronic obstructive pulmonary disease: a systematic review and meta-analysis.
    Lacasse Y; Casaburi R; Sliwinski P; Chaouat A; Fletcher E; Haidl P; Maltais F
    Lancet Respir Med; 2022 Nov; 10(11):1029-1037. PubMed ID: 35817074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Domiciliary oxygen for chronic obstructive pulmonary disease.
    Crockett AJ; Cranston JM; Moss JR; Alpers JH
    Cochrane Database Syst Rev; 2000; (4):CD001744. PubMed ID: 11034726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Oxygen Therapy in COPD Patients Who Do Not Meet the Actual Recommendations.
    Ergan B; Nava S
    COPD; 2017 Jun; 14(3):351-366. PubMed ID: 28506089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of nocturnal oxygen therapy on quality of life in patients with COPD and isolated sleep-related hypoxemia: a prospective, placebo-controlled cross-over trial].
    Orth M; Walther JW; Yalzin S; Bauer TT; de Zeeuw J; Kotterba S; Baberg HT; Schultze-Werninghaus G; Rasche K; Duchna HW
    Pneumologie; 2008 Jan; 62(1):11-6. PubMed ID: 18004709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oxygen on health quality of life in patients with chronic obstructive pulmonary disease with transient exertional hypoxemia.
    Nonoyama ML; Brooks D; Guyatt GH; Goldstein RS
    Am J Respir Crit Care Med; 2007 Aug; 176(4):343-9. PubMed ID: 17446339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind trial of nocturnal supplemental oxygen for sleep desaturation in patients with chronic obstructive pulmonary disease and a daytime PaO2 above 60 mm Hg.
    Fletcher EC; Luckett RA; Goodnight-White S; Miller CC; Qian W; Costarangos-Galarza C
    Am Rev Respir Dis; 1992 May; 145(5):1070-6. PubMed ID: 1586049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which patients with moderate hypoxemia benefit from long-term oxygen therapy? Ways forward.
    Ekström M; Ringbaek T
    Int J Chron Obstruct Pulmon Dis; 2018; 13():231-235. PubMed ID: 29386891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daytime oxygen saturation does not predict nocturnal oxygen desaturation in patients with chronic obstructive pulmonary disease.
    Mohsenin V; Guffanti EE; Hilbert J; Ferranti R
    Arch Phys Med Rehabil; 1994 Mar; 75(3):285-9. PubMed ID: 8129580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.